Jiangsu Aoyang Health Industry Co.ltd.
002172.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -5.06 | -0.16 | 2.04 | -0.02 |
| FCF Yield | -1.18% | -0.30% | -7.18% | -8.25% |
| EV / EBITDA | 15.62 | 19.52 | 25.21 | 51.92 |
| Quality | ||||
| ROIC | 4.15% | 4.57% | 3.37% | -6.86% |
| Gross Margin | 13.39% | 13.30% | 13.94% | 7.52% |
| Cash Conversion Ratio | 0.01 | 1.09 | 2.15 | 0.03 |
| Growth | ||||
| Revenue 3-Year CAGR | -0.19% | -10.47% | -13.13% | 14,468,589.97% |
| Free Cash Flow Growth | -203.51% | 95.91% | 10.85% | -390.57% |
| Safety | ||||
| Net Debt / EBITDA | 1.68 | 2.61 | 3.04 | 10.20 |
| Interest Coverage | 1.25 | 1.90 | 0.55 | -0.95 |
| Efficiency | ||||
| Inventory Turnover | 11.65 | 10.28 | 9.90 | 17.02 |
| Cash Conversion Cycle | -10.07 | -39.42 | -40.53 | 65.61 |